GSK announced the addition of Exdensur to its 340B contract pharmacy restrictions policy in a Jan. 16 notice to covered entities.

GSK Adds 340B Contract Pharmacy Restrictions to Asthma Biologic

January 23, 2026 Shannon Young, Associate Editor/Senior Writer 340B Report Views

U.K.-based pharmaceutical giant GSK recently informed 340B covered entities that a newly approved asthma biologic will be available through its [...]

Please Login or Become a Paid Subscriber to View this Content

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!